BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11727199)

  • 1. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
    Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
    Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
    Anant S; Davidson NO
    Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
    Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
    J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.
    Blanc V; Navaratnam N; Henderson JO; Anant S; Kennedy S; Jarmuz A; Scott J; Davidson NO
    J Biol Chem; 2001 Mar; 276(13):10272-83. PubMed ID: 11134005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.
    Skuse GR; Cappione AJ; Sowden M; Metheny LJ; Smith HC
    Nucleic Acids Res; 1996 Feb; 24(3):478-85. PubMed ID: 8602361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
    Mehta A; Driscoll DM
    RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
    J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
    Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants involved in regulating the proportion of edited apolipoprotein B RNAs.
    Sowden M; Hamm JK; Spinelli S; Smith HC
    RNA; 1996 Mar; 2(3):274-88. PubMed ID: 8608451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
    Greeve J; Axelos D; Welker S; Schipper M; Greten H
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
    Yang Y; Sowden MP; Smith HC
    J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker.
    Lellek H; Welker S; Diehl I; Kirsten R; Greeve J
    J Biol Chem; 2002 Jun; 277(26):23638-44. PubMed ID: 11976346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
    Mehta A; Kinter MT; Sherman NE; Driscoll DM
    Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.
    Lau PP; Zhu HJ; Nakamuta M; Chan L
    J Biol Chem; 1997 Jan; 272(3):1452-5. PubMed ID: 8999813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary structure for the apolipoprotein B mRNA editing site. Au-binding proteins interact with a stem loop.
    Richardson N; Navaratnam N; Scott J
    J Biol Chem; 1998 Nov; 273(48):31707-17. PubMed ID: 9822632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
    Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
    J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
    Siddiqui JF; Van Mater D; Sowden MP; Smith HC
    Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.